Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 2, 2009, Pages 394-400

  Krane, Vera ^a   Heinrich, Fritz ^b   Meesmann, Malte ^c   Olschewski, Manfred ^d   Lilienthal, Jürgen ^e   Angermann, Christiane ^a   Störk, Stefan ^a   Bauersachs, Johann ^a   Wanner, Christoph ^a   Frantz, Stefan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Community Hospital Bruchsal ^*  (Germany)

^c Stiftung Juliusspital   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e DATAMAP GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; PLACEBO; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE;

AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINUS RHYTHM; STROKE; SUDDEN DEATH; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; HEART ARRHYTHMIA; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTROPHY, LEFT VENTRICULAR; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PYRROLES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 66849121820     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02020408     Document Type: Article

References (27)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32[Suppl 3]: 112-119, 1998
2. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45[Suppl 3]: 1-153, 2005
3. Covic A, Diaconita M, Gusbeth-Tatomir P, Covic M, Botezan A, Ungureanu G, Goldsmith DJ: Hemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant 17: 2170-2177, 2002 (Pubitemid 35446674)
4. Madias JE: P waves in patients with changing edematous states: Implications on interpreting repeat P wave measurements in patients developing anasarca or undergoing hemodialysis. Pacing Clin Electrophysiol 27: 749-756, 2004
5. Fuenmayor AJ, Vasquez CJ, Fuenmayor AM, Winterdaal DM, Rodriguez D: Hemodialysis changes the QRS amplitude in the electrocardiogram. Int J Cardiol 41: 141-145, 1993
6. Ojanen S, Koobi T, Korhonen P, Mustonen J, Pasternack A: QRS amplitude and volume changes during hemodialysis. Am J Nephrol 19: 423-427, 1999 (Pubitemid 29301228)
7. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E, German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005 (Pubitemid 41058323)
8. Wanner C, Krane V, Marz W, Olschewski M, Asmus HG, Kramer W, Kuhn KW, Kutemeyer H, Mann JF, Ruf G, Ritz E, Deutsche Diabetes-Dialyse-Studie (4D) Study Group: Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): Demographic and baseline characteristics. Kidney Blood Press Res 27: 259-266, 2004 (Pubitemid 39279330)
9. Kannel WB, Abbott RD: A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized MI: The Framingham Study. Am Heart J 111: 391-397, 1986
10. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Dahlof B; LIFE Study Investigators: Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: The Losartan Intervention for End point Reduction in Hypertension (LIFE) study. Circulation 113: 67-73, 2006 (Pubitemid 43958490)
11. Rautaharju PM, Kooperberg C, Larson JC, LaCroix A: Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: The Women's Health Initiative. Circulation 113: 473-480, 2006 (Pubitemid 43754347)
12. Rautaharju PM, Kooperberg C, Larson JC, LaCroix A: Electrocardiographic predictors of incident congestive heart failure and all-cause mortality in postmenopausal women: The Women's Health Initiative. Circulation 113: 481-489, 2006 (Pubitemid 43754348)
13. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347: 1825-1833, 2002
14. Pedersen OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C: Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: A Danish investigation of arrhythmia and mortality on dofetilide (DIAMOND) substudy. Circulation 104: 292-296, 2001 (Pubitemid 32666950)
15. Vazquez E, Sanchez-Perales C, Lozano C, Lozano C, Garcia-Cortes MJ, Borrego F, Guzman M, Perez P, Pagola C, Borrego MJ, Perez V: Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 92: 868-871, 2003 (Pubitemid 37163591)
16. Genovesi S, Vincenti A, Rossi E, Pogliani D, Acquistapace I, Stella A, Valsecchi MG: Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 51: 255-262, 2008
17. Bots ML, Nikitin Y, Salonen JT, Elwood PC, Malyutina S, Freire de Concalves A, Sivenius J, Di Carlo A, Lagiou P, Tuomilehto J, Koudstaal PJ, Grobbee DE: Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EURO-STROKE: A collaborative study among research centers in Europe. J Epidemiol Community Health 56: S8-S13, 2002 (Pubitemid 34098450)
18. Ritz E, Wanner C: The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol 3: 920-929, 2008
19. De Lima JJ, Sesso R, Abensur H, Lopes HF, Giorgi MC, Krieger EM, Pileggi F: Predictors of mortality in long-term haemodialysis patients with a low prevalence of comorbid conditions. Nephrol Dial Transplant 10: 1708-1713, 1995
20. Koch M, Thomas B, Tschope W, Ritz E: Survival and predictors of death in dialysed diabetic patients. Diabetologia 36: 1113-1117, 1993 (Pubitemid 23288785)
21. Foley RN, Culleton BF, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Cardiac disease in diabetic endstage renal disease. Diabetologia 40: 1307-1312, 1997 (Pubitemid 27469671)
22. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5: 2024-2031, 1995
23. Nakamura S, Sasaki O, Nakahama H, Inenaga T, Kimura G: Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients. Ren Fail 24: 175-186, 2002 (Pubitemid 34596500)
24. Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M: New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension 44: 175-179, 2004 (Pubitemid 39014235)
25. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP: Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 81: 815-820, 1990 (Pubitemid 20090377)
26. Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P: Electrocardiographic left ventricular hypertrophy in renal transplant recipients: Prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 14: 462-468, 2003 (Pubitemid 36150871)
27. Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute MI among patients on long-term dialysis. N Engl J Med 339: 799-805, 1998 (Pubitemid 28447453)